Clinical Trial Update: Large-scale Trial Testing the Intensity of CYTOreductive Therapy in Polycythemia Vera (PV) [Phase 3]

View source ↗

Summary

A large Phase 3 trial evaluating the intensity of cytoreductive therapy in polycythemia vera has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• Cytoreductive therapy

Snippet

Sponsor: Consorzio Mario Negri Sud | Conditions: Polycythemia Vera | Phase 3 | Status: TERMINATED